AHCO Stock Recent News

AdaptHealth's national scale and AI-driven efficiencies position it well for value-based contracts, aiming to curb hospital readmissions and improve EBITDA margins. The company faces potential risks from competitive-bidding discounts, unresolved litigation, and execution challenges on the One Adapt ERP migration. Management's 2025 guidance suggests flat organic revenue and a 21% EBITDA margin, with shares appearing undervalued compared to peers.

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the following upcoming investor conferences: The Barclays Leveraged Finance Conference, being held in Austin, on Tuesday, May 20, 2025. The RBCCM Global Healthcare Conference, being held in New.

AdaptHealth Corp. (NASDAQ:AHCO ) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Company Participants Suzanne Foster - CEO Jason Clemens - CFO Conference Call Participants Meghan Holtz - Jefferies Pito Chickering - Deutsche Bank Eric Coldwell - Baird Kevin Caliendo - UBS Ben Hendrix - RBC Capital Markets Mathew Blackman - Stifel Whit Mayo - Leerink Partners John Pinney - Canaccord Genuity Operator Good day, everyone, and welcome to today's AdaptHealth First Quarter 2025 Earnings Release. Today's speakers will be Suzanne Foster, Chief Executive Officer of AdaptHealth; and Jason Clemens, Chief Financial Officer of AdaptHealth.

AdaptHealth Corp. (AHCO) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.02 per share a year ago.

AdaptHealth (AHCO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Investors with an interest in Medical - Products stocks have likely encountered both AdaptHealth Corp. (AHCO) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its first quarter 2025 financial results before the opening of the financial markets on Tuesday, May 6, 2025. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts an.

Although there is one day left in Q1, I'm pleased to present a detailed review of my Q1 stock picks, along with updated commentary and ratings. Today's report begins with an unconventional review of Apple, which I plan to drop coverage on. This report contains new coverage of 38 stocks that I've previously written about here at Seeking Alpha.

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the following upcoming investor conferences: The Jefferies Value-Based Healthcare Summit, being held in Miami, on Monday, March 10, 2025, including a fireside chat at 3:45pm ET. The Leerink Part.

AdaptHealth Corp specializes in sleep therapy equipment and respiratory health. These two focus segments also command the best margins for the company. Q4 2024 results exceeded expectations, driving a 30% stock surge; the company reported a record 12.3% operating income margin.